Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW ORLEANS (AP) — The U.S. Department of ...

The successful vaccine trials for honeybees, together with recent breakthrough results from clinical trials for disease prevention in shrimp, further validate the versatility of Dalan's innate ...